Keros Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.6M | 100k | 66.20 |
| 2023-12-31 | $3.8M | 95k | 39.76 |
| 2023-09-30 | $4.6M | 144k | 31.88 |
| 2023-06-30 | $4.1M | 102k | 40.18 |
| 2023-03-31 | $5.7M | 133k | 42.70 |
| 2022-12-31 | $4.5M | 94k | 48.02 |
| 2022-09-30 | $2.8M | 75k | 37.65 |
| 2022-06-30 | $1.3M | 47k | 28.07 |
| 2022-03-31 | $2.5M | 47k | 54.36 |
| 2021-12-31 | $2.7M | 46k | 58.52 |
| 2021-09-30 | $1.7M | 43k | 39.59 |
| 2021-06-30 | $1.6M | 38k | 42.46 |
| 2021-03-31 | $2.6M | 43k | 61.55 |
| 2020-12-31 | $3.0M | 43k | 70.51 |
| 2020-09-30 | $701k | 18k | 38.73 |
| 2020-06-30 | $0 | 18k | 0.00 |